San Francisco, Jan. 03, 2017 (GLOBE NEWSWIRE) --
San Francisco, CA, January 3rd, 2017 --Cytta Corp. (OTCPINK:CYCA)
Welcome to the year of Cytta. During the past year, the US, the World and Cytta have been going through momentous changes. And while the other changes have been well heralded in the press, Cytta has been laboring in relative obscurity to accomplish our goal. That goal was to complete the market ready Version 2.0 of our EvrCare™ remote medical monitoring platform, encompassing our VeriSmartPhone™ technology, and the Doctor Direct care model operating on the Oracle Cloud. And to paraphrase a somewhat tired pronouncement, we humbly hereby report “Mission Accomplished”
Throughout the year Cytta and its team of programmers have labored to upgrade the original Version 1.0 of our technology and create a more robust and fully integrated market-ready Version 2.0 remote monitoring technology we call - EvrCare™.
Under our EvrCare™ model, once the VeriSmartPhone TM receives the data from the medical peripherals, it reviews the data and decides to instigate communication via voice, video, SMS or email in real-time to the Oracle Cloud, and directly to the caregiver and back. Everything is accomplished without touching the VeriSmartPhoneTM. This provides patients with a low cost, 24/7, intelligent, instantaneous, automatic monitoring at any location at any time.
Cytta’s EvrCare™ model has been designed to utilize Oracle software in version 2.0 of our VeriSmartPhone’s TM proprietary android O/S software and online platforms. Oracle is now supplying their Database platform including analytics, security and big data to the EvrCare™ system.
Mr. Gary Campbell, CEO, states, “Our new Version 2.0 Cytta EvrCare™ remote monitoring system and the integrated online platforms responsible for the operation, viewing and storage of the data are completed, escrowed, and market ready. Additionally, we are now integrated into the world class Oracle architecture and functionality, powering our EvrCare™ system. We have begun conducting client directed presentations of our unique system, both in person and through online demonstrations that highlight our systems simplicity and ease of use. We anticipate receiving multiple opportunities for partnering, licensing as well as orders and installations for our EvrCare™ system this year.”
We have created a remote monitoring system that is fully automatic, simple to use, and cost effective for patients. However, best of all, it allows Caregivers, Physicians and Providers to provide a superior, doctor directed remote patient monitoring program that pays for itself and generates provider value-based income. Look everywhere for our upcoming ‘EvrCare™ VeriSmartPhone™ powered by Oracle’ announcements.
The genesis of the completed EvrCare™ technology began almost 18 years ago, when one of our predecessor companies, partnered with Samsung and A&D Medical, and began connecting medical peripherals to the Internet for the first time. This technology also sourced and utilized the first online medical record storage system in existence. From these humble beginnings, the idea grew and the dream took shape into the leading edge, automatic and proprietary EvrCare™ remote monitoring technology, now being offered by Cytta and our partner Oracle.
Our healthcare technology is initially being offered as a ‘prescribed’ service, monitored by your own Physician through our Doctor Direct subsidiary. Once our ‘doctor directed’ version is established in the marketplace, we anticipate expanding the model to embrace a consumer centric version. This will allow anyone to utilize our EvrCare™ VeriSmartPhone™ technology to monitor their loved ones easily, simply and economically through their own smartphone.
We wish to thank everyone who has been a part of our development efforts throughout the very long gestation period of our dream. We believe that our relative silence, while finishing Version 2.0 of our technology, allowed Cytta and the development team the opportunity to create a completely updated product version ready for the 2017 marketplace.
To us, this was not just a project to be completed, but an important and worthwhile objective which has now been achieved. We ardently hope our technology will be able to save and improve people’s lives. The EvrCare team, and all our technology partners, have performed amazingly well on this very significant and important project. Cytta Corp. will be keeping you updated on additional system developments reflecting certain other innovative elements, along with our unfolding marketing campaign in this and our other vertical markets throughout the year.
About Cytta Corp.( www.Cytta.com)
Cytta Corp. has developed an IoT remote monitoring connectivity system and is known for its Cytta Connect open source WiFi, cellular and satellite VeriSmartPhone™ platform, a highly scalable and secure IoT two-way real time monitoring solution called EvrCare™. The Cytta VeriSmartPhone™ technology consists of an ‘intelligent’ rooted android smartphone reprogrammed at the operating system level as an IoT control interface. This reprogrammed very smart device automatically connects all Bluetooth remote medical monitoring devices to the Oracle Cloud/IoT Platform, and from there to the designated recipients, creating two-way real time data, video and voice communication. The Cytta Connect technology automatically connects all remote monitoring devices to Oracle’s Cloud/IoT platform creating real time communication for all IoT market segments
About Doctor Direct Inc.( www.DoctorDirectInc.com)
The Doctor Direct or ‘doctor directed’ model is Cytta’s initial, high risk, patient remote monitoring market offering. The technology is a Physician prescribable model for patients with two or more identified morbidities. It is now complete, live patient tested in clinical trials, and has been field deployed. The Doctor Direct segment of the EvrCare™ system is completely open source – Automatically connects any Bluetooth health or wellness devices (i.e. Blood Pressure, Blood glucose, Pulse oxygen, digital scale, etc.) to the VeriSmartPhoneTM to the Oracle IoT/Cloud and on to the caregivers anywhere, and anytime.
Data is automatically received by VeriSmartPhoneTM, interpreted, assessed and recipients determined. VeriSmartPhoneTM transmits data in real time to the Dr., Nurse, Caregiver and/or family member along with determination of action level or importance. Dr., Nurse, caregiver, or family member responds to patient via voice, video, SMS or email in real-time through a VeriSmartPhoneTM in the patient’s home. The Doctor Direct remote patient monitoring system, combined with the new billing/CPT codes for the service, has created the opportunity for real-time patient monitoring and a significant revenue stream to the Physician for providing better quality care.
Safe Harbor Statement/ Forward-Looking Statements
Statements included in this press release, which are not historical in nature, are forward-looking statements made pursuant to the safe harbor provisions of the Private Securities Litigation Reform Act of 1995. Statements relating to the future performance of the Company are subject to many factors including, but not limited to, the customer acceptance of the products in the market, the introduction of competitive products and product development, the impact of any product liability or other adverse litigation, working capital and availability of capital, commercialization and technological difficulties, the impact of actions and events involving key customers, vendors, lenders, competitors, and other risks. Such statements are based upon the current beliefs and expectations of the Company's management and are subject to significant risks and uncertainties. Actual results may differ from those set forth in the forward-looking statements. When used in this press release, the terms "anticipate", "believe", "estimate", "expect", "may", "objective", "plan", "possible", "potential", "project", "will", and similar expressions identify forward-looking statements. The forward-looking statements contained in this press release are made as of the date hereof, and we do not undertake any obligation to update any forward looking statements, whether as a result of future events, new information, or otherwise.